| Literature DB >> 22291986 |
Inge Kirchberger1, Christa Meisinger, Margit Heier, Anja-Kerstin Zimmermann, Barbara Thorand, Christine S Autenrieth, Annette Peters, Karl-Heinz Ladwig, Angela Döring.
Abstract
Multimorbidity is a common problem in aged populations with a wide range of individual and societal consequences. The objective of the study was to explore patterns of comorbidity and multimorbidity in an elderly population using different analytical approaches. Data were gathered from the population-based KORA-Age project, which included 4,127 persons aged 65-94 years living in the city of Augsburg and its two surrounding counties in Southern Germany. Information on the presence of 13 chronic conditions was collected in a standardized telephone interview and a self-administered questionnaire. Patterns of comorbidity and multimorbidity were analyzed using prevalence figures, logistic regression models and exploratory tetrachoric factor analysis. The prevalence of multimorbidity (≥2 diseases) was 58.6% in the total sample. Hypertension and diabetes (Odds Ratio [OR] 2.95, 99.58% confidence interval [CI] [2.19-3.96]), as well as hypertension and stroke (OR 2.00, 99.58% CI [1.26-3.16]) most often occurred in combination. This association was independent of age, sex and the presence of other conditions. Using factor analysis, we identified four patterns of multimorbidity: the first pattern includes cardiovascular and metabolic diseases, the second includes joint, liver, lung and eye diseases, the third covers mental and neurologic diseases and the fourth pattern includes gastrointestinal diseases and cancer. 44% of the persons were assigned to at least one of the four multimorbidity patterns; 14% could be assigned to both the cardiovascular/metabolic and the joint/liver/lung/eye pattern. Further common pairs were the mental/neurologic pattern combined with the cardiovascular/metabolic pattern (7.2%) or the joint/liver/lung/eye pattern (5.3%), respectively. Our results confirmed the existence of co-occurrence of certain diseases in elderly persons, which is not caused by chance. Some of the identified patterns of multimorbidity and their overlap may indicate common underlying pathological mechanisms.Entities:
Mesh:
Year: 2012 PMID: 22291986 PMCID: PMC3264590 DOI: 10.1371/journal.pone.0030556
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Assessment of diseases in the KORA-Age Study.
| Self-report generated Charlson Comorbidity Index | KORA-Age Study | |
| Disease | Disease | Source |
| Asthma, emphysema, or chronic bronchitis | ✓ | Telephone interview |
| Arthritis or rheumatism | ✓ | Telephone interview |
| Cancer, diagnosed in the past 3 years | ✓ | Questionnaire |
| Diabetes | ✓ | Questionnaire |
| Digestive problems (such as ulcer, colitis, or gallbladder disease) | ✓ | Telephone interview |
| Heart trouble (such as angina, congestive heart failure, or coronary artery disease) | ✓ | Questionnaire, telephone interview |
| Kidney disease | ✓ | Telephone interview |
| Liver problems (such as cirrhosis) | ✓ | Telephone interview |
| Stroke | ✓ | Questionnaire |
| HIV illness or AIDS | - | Not requested |
| Neurologic diseases such as multiple sclerosis, Parkinson's disease, or epilepsy | Telephone interview | |
| Eye diseases such as glaucoma, cataract, macular degeneration, diabetic retnopathy, or retinitis pigmentosa | Telephone interview | |
| Hypertension | Questionnaire | |
| Depression | Geriatric Depression scale (GDS-15) administered via telephone interview | |
| Anxiety | Generalized Anxiety Disorder Scale-7 (GAD) administered via telephone interview |
*none of the participants reported antiretroviral therapy in the medication history.
Prevalences of the 13 chronic conditions.
| Condition | Prevalence [%] | 95% confidence interval |
| Hypertension | 57.9 | [56.3–59.4] |
| Eye disease | 38.1 | [36.6–39.6] |
| Heart disease | 25.8 | [24.4–27.1] |
| Diabetes mellitus | 16.8 | [15.6–17.9] |
| Joint disease | 16.2 | [15.1–17.4] |
| Lung disease | 10.3 | [9.4–11.2] |
| Gastrointestinal disease | 8.7 | [7.8–9.6] |
| Mental disease | 8.4 | [7.5–9.3] |
| Stroke | 7.0 | [6.2–7.8] |
| Cancer | 4.3 | [3.6–4.9] |
| Kidney disease | 4.0 | [3.4–4.6] |
| Neurological disease | 3.4 | [2.9–4.0] |
| Liver disease | 2.4 | [1.9–2.9] |
Number of conditions stratified by age group and sex.
| No. of conditions | Total sample (n = 4067) | <75 years (n = 2541) | 75–84 years (n = 1315) | ≥85 years (n = 211) | |||
| Men (n = 1225) | Women (n = 1316) | Men (n = 664) | Women (n = 651) | Men (n = 93) | Women (n = 118) | ||
| 0 | 507 (12.5%) | 211 (17.2%) | 197 (15.0%) | 57 (8.6%) | 33 (5.1%) | 3 (3.2%) | 6 (5.1%) |
| 1 | 1096 (27.0%) | 370 (30.2%) | 416 (31.6%) | 142 (21.4%) | 141 (21.7%) | 19 (20.4%) | 8 (6.8%) |
| 2 | 1093 (26.9%) | 335 (27.3%) | 357 (27.1%) | 161 (24.3%) | 186 (28.6%) | 21 (22.6%) | 33 (28.0%) |
| 3 | 713 (17.5%) | 187 (15.3%) | 193 (14.7%) | 149 (22.4%) | 129 (19.7%) | 20 (21.5%) | 35 (29.6%) |
| 4–6 | 621 (15.3%) | 116 (9.5%) | 142 (10.8%) | 147 (22.1%) | 156 (24.0%) | 28 (30.1%) | 32 (27.1%) |
| >6 | 37 (0.8%) | 6 (0.5%) | 11 (0.8%) | 8 (1.2%) | 6 (0.9%) | 2 (2.2%) | 4 (3.4%) |
| ≥2 | 2464 (60.6%) | 581 (47.4%) | 613 (46.6%) | 465 (70.0%) | 477 (73.3%) | 71 (76.3%) | 104 (88.1%) |
Most frequently co-occuring pairs of conditions and their observed and expected prevalences.
| Observed | Expected | Ratio observed/expected | Crude OR [99.58% CI] | p-value | Adjusted OR [99.58% CI] | p-value# | |
| Hypertension and eye diseases | 23.80 | 22.64 | 1.05 | 1.21 [1.01–1.46] | 0.003 | 1.04 [0.84–1.28] | 0.632 |
| Hypertension and heart diseases | 18.39 | 15.58 | 1.18 | 1.86 [1.50–2.30] | <.001 | 1.67 [1.32–2.11] | <.001 |
| Hypertension and diabetes | 13.68 | 10.11 | 1.35 | 3.20 [2.41–4.25] | <.001 | 2.95 [2.19–3.96] | <.001 |
| Hypertension and joint diseases | 10.08 | 9.70 | 1.04 | 1.13 [0.88–1.44] | 0.160 | 1.00 [0.77–1.30] | 0.992 |
| Eye diseases and diabetes | 8.11 | 6.62 | 1.22 | 1.53 [1.20–1.94] | <.001 | 1.36 [1.04–1.77] | 0.001 |
| Eye and joint diseases | 7.57 | 6.35 | 1.19 | 1.45 [1.14–1.85] | <.001 | 1.25 [0.96–1.63] | 0.018 |
| Hypertension and lung diseases | 6.78 | 6.23 | 1.09 | 1.28 [0.95–1.73] | 0.020 | 1.13 [0.82–1.57] | 0.268 |
| Heart diseases and diabetes | 6.39 | 4.56 | 1.40 | 1.84 [1.43–2.36] | <.001 | 1.46 [1.11–1.92] | <.001 |
| Eye and lung diseases | 5.43 | 4.08 | 1.33 | 1.81 [1.35–2.42] | <.001 | 1.65 [1.20–2.28] | <.001 |
| Hypertension and stroke | 5.32 | 4.12 | 1.29 | 2.39 [1.59–3.59] | <.001 | 2.00 [1.26–3.16] | <.001 |
| Heart diseases and joint diseases | 5.31 | 4.37 | 1.21 | 1.40 [1.08–1.82] | 0.002 | 1.24 [0.93–1.64] | 0.034 |
| Hypertension and gastrointestinal diseases | 5.30 | 4.70 | 1.13 | 1.07 [0.77–1.47] | 0.562 | 0.93 [0.66–1.31] | 0.530 |
Results from logistic regression models testing the association between pairs of conditions.
*Odds ratios (OR) were adjusted for age, sex and all other diseases.
Number and percent of persons who could be assigned to the multimorbidity patterns.
| Total (n = 2846) | Men (n = 1411) | Women (n = 1435) | p-value | <75 years (n = 1439) | 75–84 years (n = 1174) | ≥85 years (n = 233) | p-value | |
| Cardiovascular/metabolic disorders | 1314 (31.8%) | 699 (34.7%) | 615 (29.1%) | <0.01 | 678 (47.1%) | 539 (45.9%) | 97 (41.6%) | <0.01 |
| Liver/lung/joint/eye disorders | 1041(25.2%) | 479 (23.7%) | 562 (26.7%) | 0.04 | 490 (34.1%) | 456 (38.8%) | 95 (40.8%) | <0.01 |
| Mental/neurologic disorders | 398 (9.7%) | 187 (9.3%) | 211 (10.0%) | 0.44 | 219 (15.2%) | 150 (12.8%) | 29 (12.4%) | <0.01 |
| Gastrointestinal disorders and cancer | 93 (2.3%) | 46 (2.3%) | 47 (2.2%) | 0.90 | 52 (3.6%) | 29 (2.5%) | 12 (5.2%) | 0.01 |
Results of Chi2-test for sex and age-group differences.